"Company†), a clinical-stage biotechnology company developing dermatology, wound care, and anti- infective therapies, today announced that it expects its common stock will begin trading on the Nasdaq Global Market under the ticker symbol "TTRX†on October 8, 2025. Copies of the prospectus, when available, may be obtained from Turn Therapeutics, 250 N. Westlake Blvd., Westlake Village, CA 91362. About Turn Therapeutics Tu. WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Turn Therapeutics ("Turn†or the ...